BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15758948)

  • 1. Acute intravenous low- and high-dose cocaine reduces quantitative global and regional cerebral blood flow in recently abstinent subjects with cocaine use disorder.
    Johnson BA; Dawes MA; Roache JD; Wells LT; Ait-Daoud N; Mauldin JB; Wang Y; Lancaster JL; Fox PT
    J Cereb Blood Flow Metab; 2005 Jul; 25(7):928-36. PubMed ID: 15758948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered resting cerebral blood flow in adolescents with in utero cocaine exposure revealed by perfusion functional MRI.
    Rao H; Wang J; Giannetta J; Korczykowski M; Shera D; Avants BB; Gee J; Detre JA; Hurt H
    Pediatrics; 2007 Nov; 120(5):e1245-54. PubMed ID: 17974718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isradipine decreases the hemodynamic response of cocaine and methamphetamine results from two human laboratory studies: results from two human laboratory studies.
    Johnson BA; Wells LT; Roache JD; Wallace C; Ait-Daoud N; Wang Y
    Am J Hypertens; 2005 Jun; 18(6):813-22. PubMed ID: 15925741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocaine-induced brain activation determined by positron emission tomography neuroimaging in conscious rhesus monkeys.
    Howell LL; Hoffman JM; Votaw JR; Landrum AM; Wilcox KM; Lindsey KP
    Psychopharmacology (Berl); 2002 Jan; 159(2):154-60. PubMed ID: 11862343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers.
    Jones HE; Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 1999 Jan; 288(1):188-97. PubMed ID: 9862770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of repeated-dose isradipine on the abuse liability of cocaine.
    Roache JD; Johnson BA; Ait-Daoud N; Mauldin JB; Thornton JE; Wells LT; Murff WL
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):319-26. PubMed ID: 16366762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of dose-dependent global and regional cocaine-induced reductions in brain blood flow using a novel approach to quantitative single photon emission computerized tomography.
    Johnson B; Lamki L; Fang B; Barron B; Wagner L; Wells L; Kenny P; Overton D; Dhother S; Abramson D; Chen R; Kramer L
    Neuropsychopharmacology; 1998 May; 18(5):377-84. PubMed ID: 9536451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral cocaine on intravenous cocaine discrimination in humans.
    Johanson CE; Lundahl LH; Schubiner H
    Exp Clin Psychopharmacol; 2007 Jun; 15(3):219-27. PubMed ID: 17563208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography.
    Kaufman MJ; Levin JM; Ross MH; Lange N; Rose SL; Kukes TJ; Mendelson JH; Lukas SE; Cohen BM; Renshaw PF
    JAMA; 1998 Feb; 279(5):376-80. PubMed ID: 9459471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine effects on digital blood flow and diffusing capacity for carbon monoxide among chronic cocaine users.
    Sullivan JT; Becker PM; Preston KL; Wise RA; Wigely FM; Testa MP; Jasinski DR
    Am J Med; 1997 Mar; 102(3):232-8. PubMed ID: 9217590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiogenesis in adult rats treated chronically with cocaine during adolescence: effects of extended abstinence and 8-OH-DPAT treatment.
    Santucci AC; Madeira E
    Brain Res Bull; 2008 Jul; 76(4):402-11. PubMed ID: 18502317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 5-HT1B/1D receptor agonist rizatriptan on cerebral blood flow and blood volume in normal circulation.
    Okazawa H; Tsuchida T; Pagani M; Mori T; Kobayashi M; Tanaka F; Yonekura Y
    J Cereb Blood Flow Metab; 2006 Jan; 26(1):92-8. PubMed ID: 15944648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cortisol and cocaine on plasma prolactin and growth hormone levels in cocaine-dependent volunteers.
    Elman I; Lukas SE
    Addict Behav; 2005 May; 30(4):859-64. PubMed ID: 15833589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective effects of cocaine on regional cerebral blood flow in the rat.
    Stein EA; Fuller SA
    J Pharmacol Exp Ther; 1992 Jul; 262(1):327-34. PubMed ID: 1625206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective and cardiovascular effects of cocaine during treatment with amantadine and baclofen in combination.
    Rotheram-Fuller E; De La Garza R; Mahoney JJ; Shoptaw S; Newton TF
    Psychiatry Res; 2007 Aug; 152(2-3):205-10. PubMed ID: 17449110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects.
    Foltin RW; Haney M
    Pharmacol Biochem Behav; 2004 May; 78(1):93-101. PubMed ID: 15159138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
    Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
    Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cocaine in an experimental model of traumatic brain injury.
    McBeth BD; Stern SA; Wang X; Mertz M; Zink BJ
    Acad Emerg Med; 2005 Jun; 12(6):483-90. PubMed ID: 15930397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of binge cocaine treatment on hindlimb vascular function.
    Pradhan L; Dabisch PA; Liles JT; Murthy SN; Baber SR; Simpson SA; Agrawal KC; Kadowitz PJ
    J Appl Toxicol; 2005; 25(6):479-90. PubMed ID: 16092079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.